Caption Management, LLC Regenxbio Inc. Call Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $304,250 - $615,250	-25,000 Reduced 55.56%	20,000 $421,000
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $580,050 - $936,900	45,000 New	45,000 $807,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $61,199 - $74,190	-3,000 Reduced 10.0%	27,000 $612,000
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $580,500 - $1.05 Million	30,000 New	30,000 $741,000
Q1 2022 May 13, 2022	SELL	$24.62 - $34.31 $738,600 - $1.03 Million	-30,000 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $486,900 - $607,200	15,000 Added 100.0%	30,000 $1.17 Million
Q1 2021 May 17, 2021	SELL	$33.61 - $49.95 $504,150 - $749,250	-15,000 Reduced 50.0%	15,000 $512,000
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $397,800 - $740,250	-15,000 Reduced 33.33%	30,000 $1.36 Million
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $1.22 Million - $1.81 Million	45,000 New	45,000 $1.24 Million

193

42.1M

80.6K

55.2K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.